Alexandra L. Degenhardt

Alexandra Degenhardt practices at Alfond Center for Health in Augusta, Maine.

Alexandra Degenhardt's NPI, 1649378829, was assigned on September 20, 2006. Alexandra Degenhardt holds New York license 241309.

Alexandra Degenhardt's primary practice is Alfond Center for Health, at 35 Medical Center Pkwy, Augusta, ME 04330 in Kennebec County. The practice phone is (207) 873-9841.

Alexandra Degenhardt's primary practice is Alfond Center for Health in Augusta, Maine. Alexandra Degenhardt is also affiliated with MaineGeneral Medical Center. The medical group on file is MaineGeneral Health. Dmand AI also links Alexandra Degenhardt to 5 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alexandra Degenhardt practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Alexandra Degenhardt's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Alexandra Degenhardt is licensed in New York.

CMS data shows 293 Medicare services from Alexandra Degenhardt across 5 procedure codes in 2024, all of them office visits, for 179 Medicare patients. Medicare paid $21,461 for them. Every service was in an office.

CMS counts 179 Medicare patients who saw Alexandra Degenhardt in 2024. The largest group is under 65, with 68 patients. 53% of them have high cholesterol, and 51% have high blood pressure. 41% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Alexandra Degenhardt's median patient age at 64, with 63% women.

In 2024, Alexandra Degenhardt wrote 3,819 Medicare Part D claims for 394 patients. 89% of them were for generic drugs. CMS names the drug for 3,515 of them, across 76 drugs with 11 or more claims each, at $2,638,099 in total drug cost. In 2023, CMS named 2,987 claims across 66 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Alexandra Degenhardt for performance year 2024, reported as part of a group. Alexandra Degenhardt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alexandra Degenhardt as offering telehealth.

CMS Open Payments shows 156 general payments to Alexandra Degenhardt from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Biogen, Inc. paid the most, $77,604.